CBD cosmetics and sensitive skin: what France allows

Eczema — an umbrella term covering atopic dermatitis, contact dermatitis, dyshidrotic eczema and several other forms — falls under dermatological care. The Haute Autorité de Santé recommends a stepped approach: regular emollients, topical corticosteroids during flare-ups, topical immunomodulators as second line, biologics in severe forms.

No cosmetic is a substitute for that pathway. The distinction is legal before it is medical: a product claiming to "treat" or "cure" eczema would be reclassified as a medicine by presentation within the meaning of article L.5111-1 of the French Public Health Code.

Of all the CBD categories, cosmetics enjoy the most stable legal regime. Cannabidiol has been listed since February 2021 in the European Commission's CosIng (Cosmetic Ingredients Database). The European Commission also authorised the use of hemp leaves in cosmetics in 2024.

That listing makes them marketable under regulation (EC) No 1223/2009, provided that:

• The product is notified on the European CPNP portal before being placed on the market;
• A product information file (PIF) is kept available for the ANSM;
• A responsible person is identified within the European Union;
• The product contains no THC above the acceptable contamination threshold.

The Novel Food regulation does not apply to cosmetics, which sets them apart from CBD food supplements, restricted since 15 May 2026.

Regulation (EU) No 655/2013 governs cosmetic claims against six criteria: legal compliance, truthfulness, evidential support, honesty, fairness, and informed decision-making by the consumer. For a topical CBD product intended for sensitive skin, the acceptable wordings remain factual or aesthetic:

• "Hydration and skin comfort";
• "Soothes sensations of skin discomfort";
• "For sensitive skin";
• "Skin barrier care";
• "Relaxing massage for tense areas".

The wordings that are prohibited because they are therapeutic:

• "Treats eczema";
• "Anti-inflammatory";
• "Relieves psoriasis";
• "Heals";
• "Reduces itching linked to a skin condition";
• "An alternative to topical corticosteroids".

The line is a precise one: a cosmetic may improve the appearance and comfort of the skin; it may not act on a disease.

A classic formulation for reactive skin combines:

• Hemp extract standardised for CBD;
• Plant butters (shea, cocoa) for the fatty phase;
• Oils rich in omega-3 (hemp oil, camelina oil);
• Beeswax or plant waxes (candelilla, carnauba) for texture;
• Traditional soothing agents (calendula, bisabolol, allantoin, panthenol);
• Preservatives compliant with Annex V of the cosmetics regulation.

Several of these ingredients — panthenol, allantoin, bisabolol — have solid dermatological documentation and are also found in pharmacy skincare. CBD is added to that base without changing its cosmetic nature.

The ANSM runs the national cosmetovigilance system, which collects reports of adverse effects linked to cosmetic products. Any unexpected reaction (redness, itching, erythema, contact urticaria) should be reported:

• To the manufacturer (via the contact details on the packaging);
• To the ANSM (reporting portal);
• To a healthcare professional if the symptom persists.

Reporting makes collective risk assessment possible and, where appropriate, the withdrawal or reformulation of the product. The 2024 inspections by the DGCCRF found a non-compliance rate of around 15 % across French CBD products.

Before applying a new cosmetic over a large area or to sensitised skin, a test on the inner elbow over 48 hours will reveal any individual intolerance. This precaution is particularly relevant for atopic skin, which is more likely to react to concentrated plant ingredients.

• CBD has been listed in the European CosIng database since 2021: CBD cosmetics are legal in France.
• No therapeutic claim about eczema or any skin condition is permitted for a cosmetic.
• A CBD cosmetic does not replace the dermatological care recommended by the HAS.
• The Novel Food regulation does not apply to cosmetics (unlike ingestibles since 15 May 2026).
• Test a new product on the inner elbow for 48 hours before applying it widely.

Can a CBD cosmetic "cure" eczema?

No. Claiming to cure a skin condition is a therapeutic claim, reserved for medicines with a marketing authorisation. At most, a cosmetic can contribute to skin comfort and hydration, alongside medical care.

Should you see a dermatologist before using a CBD balm?

If you have an active skin condition or one that is being medically monitored, yes. The healthcare professional can judge whether the product is compatible with your treatment and rule out any interaction or worsening.

What does "CBD" mean on a cosmetic's INCI list?

The CosIng listing uses several names depending on the form: "Cannabidiol" for the isolated molecule, "Cannabis Sativa Leaf Extract" for a leaf extract, "Cannabis Sativa Seed Oil" for seed oil (which contains no CBD).

Can a CBD cosmetic cause a positive saliva test for THC?

Transdermal absorption of THC from a compliant cosmetic is generally negligible. The risk of a positive saliva test remains theoretical, but no study has established a contamination threshold to worry about for normal cosmetic use.

How does it differ from a pharmacy topical corticosteroid?

A topical corticosteroid is a medicine with a marketing authorisation, an indication, a dosage and a duration of use governed by prescription. A CBD cosmetic is an everyday consumer product, with no therapeutic purpose, whose effectiveness against a disease has not been assessed.

CBD is not a medicine. If you have a chronic skin condition or a persistent skin symptom, consult a dermatologist. To explore our selection of CBD cosmetics, [browse our catalogue](/categorie-produit).

• Conseil d'État, 29 Dec. 2022, no. 444887 (flowers/leaves) — primary
• French Public Health Code, art. L.5111-1 (definition of a medicine) — primary
• Directive 2014/40/EU (TPD) — primary